APA

Savaş E. M., Oğuz S. H., Samadi A., Yılmaz Işıkhan S., Ünlütürk U., Lay İ. & Gürlek A. (20210607). Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study. : Metabolic syndrome and related disorders.

Chicago

Savaş Emine Merve, Oğuz Seda Hanife, Samadi Afshin, Yılmaz Işıkhan Selen, Ünlütürk Uğur, Lay İncilay and Gürlek Alper. 20210607. Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study. : Metabolic syndrome and related disorders.

Harvard

Savaş E. M., Oğuz S. H., Samadi A., Yılmaz Işıkhan S., Ünlütürk U., Lay İ. and Gürlek A. (20210607). Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study. : Metabolic syndrome and related disorders.

MLA

Savaş Emine Merve, Oğuz Seda Hanife, Samadi Afshin, Yılmaz Işıkhan Selen, Ünlütürk Uğur, Lay İncilay and Gürlek Alper. Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study. : Metabolic syndrome and related disorders. 20210607.